First National Bank Sioux Falls’s iShares Biotechnology ETF IBB Stock Holding History

First National Bank Sioux Falls’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,000	Closed	-$274K	–	127
2024 Q1	$274K	Sell	2,000 -1,620	-45%	-$221K	0.15%	112
2023 Q4	$492K	Hold	3,620	–	–	0.25%	74
2023 Q3	$443K	Buy	+3,620	New	+$460K	0.26%	73

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

First National Bank Sioux Falls's IBB Position: Q2 2024 in Review

First National Bank Sioux Falls sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 2,000 shares — an estimated $274K sold.

First National Bank Sioux Falls first reported a position in IBB in Q3 2023 and held it in 3 quarters. The position peaked at $492K in Q4 2023. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

First National Bank Sioux Falls reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
First National Bank Sioux Falls sold 2,000 iShares Biotechnology ETF shares in Q2 2024, an estimated $274K.
First National Bank Sioux Falls first reported a position in iShares Biotechnology ETF in Q3 2023 and held it in 3 quarters.
First National Bank Sioux Falls's iShares Biotechnology ETF position peaked at $492K in Q4 2023.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on First National Bank Sioux Falls's 13F filing for Q2 2024, filed 31 Jul 2024.